These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 27382027

  • 1. An RYR1 mutation associated with malignant hyperthermia is also associated with bleeding abnormalities.
    Lopez RJ, Byrne S, Vukcevic M, Sekulic-Jablanovic M, Xu L, Brink M, Alamelu J, Voermans N, Snoeck M, Clement E, Muntoni F, Zhou H, Radunovic A, Mohammed S, Wraige E, Zorzato F, Treves S, Jungbluth H.
    Sci Signal; 2016 Jul 05; 9(435):ra68. PubMed ID: 27382027
    [Abstract] [Full Text] [Related]

  • 2. Reduced threshold for store overload-induced Ca2+ release is a common defect of RyR1 mutations associated with malignant hyperthermia and central core disease.
    Chen W, Koop A, Liu Y, Guo W, Wei J, Wang R, MacLennan DH, Dirksen RT, Chen SRW.
    Biochem J; 2017 Aug 07; 474(16):2749-2761. PubMed ID: 28687594
    [Abstract] [Full Text] [Related]

  • 3. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV, Quane KA, Lynch PJ.
    Hum Mutat; 2000 Aug 07; 15(5):410-7. PubMed ID: 10790202
    [Abstract] [Full Text] [Related]

  • 4. Gene dose influences cellular and calcium channel dysregulation in heterozygous and homozygous T4826I-RYR1 malignant hyperthermia-susceptible muscle.
    Barrientos GC, Feng W, Truong K, Matthaei KI, Yang T, Allen PD, Lopez JR, Pessah IN.
    J Biol Chem; 2012 Jan 20; 287(4):2863-76. PubMed ID: 22139840
    [Abstract] [Full Text] [Related]

  • 5. A retrograde signal from RyR1 alters DHP receptor inactivation and limits window Ca2+ release in muscle fibers of Y522S RyR1 knock-in mice.
    Andronache Z, Hamilton SL, Dirksen RT, Melzer W.
    Proc Natl Acad Sci U S A; 2009 Mar 17; 106(11):4531-6. PubMed ID: 19246389
    [Abstract] [Full Text] [Related]

  • 6. Malignant hyperthermia-associated mutations in the S2-S3 cytoplasmic loop of type 1 ryanodine receptor calcium channel impair calcium-dependent inactivation.
    Gomez AC, Holford TW, Yamaguchi N.
    Am J Physiol Cell Physiol; 2016 Nov 01; 311(5):C749-C757. PubMed ID: 27558158
    [Abstract] [Full Text] [Related]

  • 7. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
    Ta TA, Pessah IN.
    Neurotoxicology; 2007 Jul 01; 28(4):770-9. PubMed ID: 17023049
    [Abstract] [Full Text] [Related]

  • 8. Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR.
    Yang T, Esteve E, Pessah IN, Molinski TF, Allen PD, López JR.
    Am J Physiol Cell Physiol; 2007 May 01; 292(5):C1591-8. PubMed ID: 17182726
    [Abstract] [Full Text] [Related]

  • 9. Exercise-induced rhabdomyolysis and stress-induced malignant hyperthermia events, association with malignant hyperthermia susceptibility, and RYR1 gene sequence variations.
    Carsana A.
    ScientificWorldJournal; 2013 May 01; 2013():531465. PubMed ID: 23476141
    [Abstract] [Full Text] [Related]

  • 10. Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect Of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors.
    Censier K, Urwyler A, Zorzato F, Treves S.
    J Clin Invest; 1998 Mar 15; 101(6):1233-42. PubMed ID: 9502764
    [Abstract] [Full Text] [Related]

  • 11. Strenuous exercise triggers a life-threatening response in mice susceptible to malignant hyperthermia.
    Michelucci A, Paolini C, Boncompagni S, Canato M, Reggiani C, Protasi F.
    FASEB J; 2017 Aug 15; 31(8):3649-3662. PubMed ID: 28465322
    [Abstract] [Full Text] [Related]

  • 12. Functional and biochemical properties of ryanodine receptor type 1 channels from heterozygous R163C malignant hyperthermia-susceptible mice.
    Feng W, Barrientos GC, Cherednichenko G, Yang T, Padilla IT, Truong K, Allen PD, Lopez JR, Pessah IN.
    Mol Pharmacol; 2011 Mar 15; 79(3):420-31. PubMed ID: 21156754
    [Abstract] [Full Text] [Related]

  • 13. Eccentric contractions do not induce rhabdomyolysis in malignant hyperthermia susceptible mice.
    Corona BT, Rouviere C, Hamilton SL, Ingalls CP.
    J Appl Physiol (1985); 2008 Nov 15; 105(5):1542-53. PubMed ID: 18787086
    [Abstract] [Full Text] [Related]

  • 14. The effects of dantrolene in the presence or absence of ryanodine receptor type 1 variants in individuals predisposed to malignant hyperthermia.
    Noda Y, Mukaida K, Miyoshi H, Nakamura R, Yasuda T, Saeki N, Nishino I, Tsutsumi YM.
    Anaesth Intensive Care; 2022 Jul 15; 50(4):312-319. PubMed ID: 35549722
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nonspecific sarcolemmal cation channels are critical for the pathogenesis of malignant hyperthermia.
    Eltit JM, Ding X, Pessah IN, Allen PD, Lopez JR.
    FASEB J; 2013 Mar 15; 27(3):991-1000. PubMed ID: 23159934
    [Abstract] [Full Text] [Related]

  • 17. Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse.
    Yang T, Riehl J, Esteve E, Matthaei KI, Goth S, Allen PD, Pessah IN, Lopez JR.
    Anesthesiology; 2006 Dec 15; 105(6):1164-75. PubMed ID: 17122579
    [Abstract] [Full Text] [Related]

  • 18. RyR1-specific requirement for depolarization-induced Ca2+ sparks in urinary bladder smooth muscle.
    Fritz N, Morel JL, Jeyakumar LH, Fleischer S, Allen PD, Mironneau J, Macrez N.
    J Cell Sci; 2007 Nov 01; 120(Pt 21):3784-91. PubMed ID: 17925380
    [Abstract] [Full Text] [Related]

  • 19. Divergent effects of the malignant hyperthermia-susceptible Arg(615)-->Cys mutation on the Ca(2+) and Mg(2+) dependence of the RyR1.
    Balog EM, Fruen BR, Shomer NH, Louis CF.
    Biophys J; 2001 Oct 01; 81(4):2050-8. PubMed ID: 11566777
    [Abstract] [Full Text] [Related]

  • 20. Identification of genetic mutations in Australian malignant hyperthermia families using sequencing of RYR1 hotspots.
    Gillies RL, Bjorksten AR, Davis M, Du Sart D.
    Anaesth Intensive Care; 2008 May 01; 36(3):391-403. PubMed ID: 18564801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.